
Data Soft Logic (DSL) · Company stories
Reliq & DSL: Understanding the July 2022 Go-Live Announcement
What Reliq’s reported first-client milestone establishes—and what agencies should verify today.
Announcement date: July 19, 2022
01 / Source-backed context
The story behind the reference
In July 2022, Reliq Health Technologies reported that its first client through the DSL partnership had gone live and that onboarding had begun. The original GlobeNewswire release is dated July 19, 2022.
Announcement date: July 19, 2022
Source: Reliq via GlobeNewswireThe milestone is attributed to Reliq, not independently audited by DSL’s editorial team. It does not establish broader adoption, achieved growth forecasts, patient outcomes or current iUGO Care availability. No client identity or agency counts are reproduced.
02 / From context to evaluation
Bring the conversation back to your agency
A reported go-live is different from a general availability commitment. Agency leaders should evaluate the current service scope, support ownership and operational readiness rather than extrapolating from a historical milestone.
01
What is available now, rather than what was announced in 2022?
02
Who supports the agency if a handoff between systems fails?
03
What validation and readiness steps are agreed before a new go-live?
03 / Current product context
Explore DSL today
DSL provides home health, hospice and therapy software. Evaluate the current product, its configuration and your agency’s workflow—not availability inferred from historical coverage.
AI-assisted documentation remains subject to clinician review and approval. DSL does not provide AI coding or guarantee coding accuracy. Current iUGO Care availability must be verified separately; historical coverage is not a compliance certification or a clinical-outcome guarantee.

See your workflow in a DSL demonstration
DSL company editorial · November 16, 2026. Original commentary, not source republication. No excerpts, publisher artwork or award badges are reproduced; reuse permission remains unconfirmed.